What is the equity of DermTech this year?
DermTech has equity of 57.17 M USD this year.
DermTech Equity 2024
DermTech Equity
57.17 M USD
Ticker
DMTK
ISIN
US24984K1051
In 2024, DermTech's equity was 57.17 M USD, a -56.82% increase from the 132.4 M USD equity in the previous year.
DermTech Aktienanalyse
What does DermTech do?
DermTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing DermTech's Equity
DermTech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding DermTech's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating DermTech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
DermTech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in DermTech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about DermTech stock
What was the equity of DermTech compared to the previous year?
The equity of DermTech has increased/decreased by -56.82% decreased compared to the previous year.
What impact does a high equity have on investors of DermTech?
A high equity is advantageous for investors of DermTech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of DermTech?
A low equity can be a risk for investors of DermTech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of DermTech affect the company?
An increase in equity of DermTech can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of DermTech affect the company?
A reduction in equity of DermTech can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of DermTech?
Some factors that can affect the equity of DermTech include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of DermTech so important for investors?
The equity of DermTech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can DermTech take to change the equity?
To change equity, DermTech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does DermTech pay?
Over the past 12 months, DermTech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DermTech is expected to pay a dividend of 0 USD.
What is the dividend yield of DermTech?
The current dividend yield of DermTech is .
When does DermTech pay dividends?
DermTech pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DermTech?
DermTech paid dividends every year for the past 0 years.
What is the dividend of DermTech?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is DermTech located?
DermTech is assigned to the 'Health' sector.
Wann musste ich die Aktien von DermTech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DermTech from 12/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.
When did DermTech pay the last dividend?
The last dividend was paid out on 12/24/2024.
What was the dividend of DermTech in the year 2023?
In the year 2023, DermTech distributed 0 USD as dividends.
In which currency does DermTech pay out the dividend?
The dividends of DermTech are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DermTech
Our stock analysis for DermTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DermTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.